Find your way into Dropprint Genomics
Sign up to see every warm intro you have to Dropprint Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dropprint Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Dropprint Genomics develops software for analyzing individual cell activity in genomic data, serving researchers in immunology and drug discovery. The company reduces the cost and computational complexity of single-cell sequencing and maintains a database of over 1 million immune cells to support target identification using machine learning models.
Founders & leadership· Y Combinator alumni (W20)
RG

MS

Meena SubramaniamCTO & Co-Founder2019–2021Meena Subramaniam is a computational biologist with experience in single-cell RNA sequencing and genomic data analysis for target discovery. She has previously founded and exited a startup, and has worked in seed-stage ventures collaborating on machine learning models and data processing infrastructure.
Investors · 1
Related companies · 4
One CodexOne Codex operates a data platform for applied microbial genomics and metagenomics, supporting applications in clinical diagnostics, food safety, and biosecurity. The company was acquired by Invitae in 2021 and spun out as independent in 2022.
Luminist LabsLuminist Labs built a non-invasive diagnostic test for early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). The company was acquired by DiscernDx in 2020.
BillionToOneBillionToOne builds a DNA molecular counting technology that increases the resolution of cell-free DNA diagnostics, applied to prenatal screening and liquid biopsy for cancer. Its products serve clinical genetic testing in prenatal care and oncology.
Helix NanotechnologiesHelixNano develops an mRNA platform aimed at applications including cancer treatment, COVID-19 vaccines, and environmental interventions. The company is working on a COVID-19 vaccine candidate for immunocompromised patients and other mRNA-based technologies.
Companies working in the same space as Dropprint Genomics.
Legal entities · 1
corporate structureDropprint Genomics Inc.
Frequently asked questions
- What does Dropprint Genomics do?
- Dropprint Genomics develops software for analyzing individual cell activity in genomic data, serving researchers in immunology and drug discovery. The company reduces the cost and computational complexity of single-cell sequencing and maintains a database of over 1 million immune cells to support target identification using machine learning models.
- Who founded Dropprint Genomics?
- Dropprint Genomics was founded by Rachel Gate, Meena Subramaniam, Jimmie Ye.
- Who are Dropprint Genomics's investors?
- Dropprint Genomics's investors include Y Combinator.
- Who acquired Dropprint Genomics?
- Dropprint Genomics was acquired by Immunai.
- Where is Dropprint Genomics headquartered?
- Dropprint Genomics is headquartered in San Francisco, US.






